Details of the Drug

General Information of Drug (ID: DM4J9AI)

Drug Name

BNT313

Synonyms

GEN1053

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05435339) First-in-Human, Open-label, Dose-Escalation Trial With an Expansion Cohort to Evaluate the Safety of GEN1053 as Monotherapy in Subjects With Malignant Solid Tumors. U.S.National Institutes of Health.